Cite
MLA Citation
Jonathan P Piccini et al.. “Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.” Lancet, vol. 399, no. 10333, 2022, pp. 1383–1390. http://access.bl.uk/ark:/81055/vdc_100153434364.0x000047